Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, December 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 35 Mendeley
citeulike: 1 CiteULike

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,838 followers.

Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study. #amchelsinki #tutkimus https://t.co/rMHglUgdTx

19 Dec 2018

Reply Repost Favourite

Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study https://t.co/YEevCAJQMF

16 Dec 2018

Reply Repost Favourite